PG
INSY

PEAK6 Group’s Insys Therapeutics, Inc. INSY Stock Holding History

PEAK6 Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50,000
Closed -$302K – 5279
2018
Q1 		$302K Buy
+50,000
New +$413K ﹤0.01% 3040
2016
Q1 		– Sell
-5,000
Closed -$143K – 5335
2015
Q4 		$143K Sell
5,000
-8,000
-62% -$222K ﹤0.01% 3712
2015
Q3 		$370K Sell
13,000
-164,700
-93% -$6.06M ﹤0.01% 3176
2015
Q2 		$6.38M Buy
+177,700
New +$5.53M 0.04% 686

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PEAK6 Group's INSY Position: Q2 2018 in Review

PEAK6 Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2018, closing a stake of 17,850 shares — an estimated $108K sold.

PEAK6 Group first reported a position in INSY in Q1 2018 and held it in 1 quarter. The position peaked at $108K in Q1 2018. 103 funds tracked by Wall St. Rank hold INSY as of Q2 2018.

  • PEAK6 Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 17,850 Insys Therapeutics, Inc. shares in Q2 2018, an estimated $108K.
  • PEAK6 Group first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
  • PEAK6 Group's Insys Therapeutics, Inc. position peaked at $108K in Q1 2018.
  • 103 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.